Literature DB >> 9057423

Ethnic differences in the frequency distribution of serum cholinesterase activity.

J Hosseini1, F Firuzian, J Feely.   

Abstract

We studied the activity of the enzyme pseudocholinesterase (serum cholinesterase) and its sensitivity to inhibition by dibucaine and fluoride in 400 (200 Iranian and 200 Irish) healthy subjects. The results show Irish subjects have significantly higher serum cholinesterase activity than Iranian subjects (7.82 +/- 0.14 vs 5.22 +/- 0.09 u/ml, mean +/- SEM, p < 0.01). Furthermore, the percent of inhibition of enzyme activity by dibucaine (82.19 +/- 0.68 vs 69.29 +/- 0.68) and fluoride (79.90 +/- 70.13 +/- 0.62) was also significantly higher (p < 0.001) in Irish than in Iranian subjects. One subject (Iranian) with very low pseudocholinesterase activity and a dibucaine number below 20 (atypical) had a history of apnoea following succinylcholine (suxamethonium). These data indicate that the frequency of atypical and heterozygote genes for cholinesterase activity leading to prolonged apnoea is much higher in Iranian than Irish populations. This study emphasises the importance of ethnic pharmacology.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9057423     DOI: 10.1007/bf02939767

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  9 in total

1.  Genetical studies on a new variant of serum cholinesterase detected by electrophoresis.

Authors:  H HARRIS; D A HOPKINSON; E B ROBSON; M WHITTAKER
Journal:  Ann Hum Genet       Date:  1963-06       Impact factor: 1.670

2.  A method for the detection of atypical forms of human serum cholinesterase; determination of dibucaine numbers.

Authors:  W KALOW; K GENEST
Journal:  Can J Biochem Physiol       Date:  1957-06

3.  The relation between dose of succinylcholine and duration of apnea in man.

Authors:  W KALOW; D R GUNN
Journal:  J Pharmacol Exp Ther       Date:  1957-06       Impact factor: 4.030

4.  Colorimetric determination of serum cholinesterase and its genetic variants by the propionylthiocholine-dithiobis(nitrobenzoic acid)procedure.

Authors:  A A Dietz; H M Rubinstein; T Lubrano
Journal:  Clin Chem       Date:  1973-11       Impact factor: 8.327

5.  Population genetic studies of serum protein polymorphisms in four Spanish populations. II.

Authors:  H W Goedde; L Hirth; H G Benkmann; A Pellicer; T Pellicer; M Stahn; S Singh
Journal:  Hum Hered       Date:  1973       Impact factor: 0.444

6.  High frequency of atypical pseudocholinesterase gene among Iraqi and Iranian Jews.

Authors:  A Szeinberg; S Pipano; M Assa; J H Medalie; H N Neufeld
Journal:  Clin Genet       Date:  1972       Impact factor: 4.438

7.  Frequencies of pseudocholinesterase variants in Icelanders, Greeks and Pakistanis.

Authors:  S Neumann; H Walter
Journal:  Nature       Date:  1968-08-31       Impact factor: 49.962

8.  E1h, a new allele at cholinesterase locus 1.

Authors:  M Whittaker; J J Britten
Journal:  Hum Hered       Date:  1987       Impact factor: 0.444

9.  Plasma cholinesterase variants in population samples from south-west France.

Authors:  H Vergnes; J Sevin; M Peralta
Journal:  Ann Hum Biol       Date:  1981 Jan-Feb       Impact factor: 1.533

  9 in total
  4 in total

1.  Pseudo-cholinesterase polymorphism in Mazandaran province (North of Iran).

Authors:  Ebrahim Zabihi; Meisam Shabanzadeh; Sina Arabsheibani; Ali Akbar Moghadamnia; Mahmoud Baradaran
Journal:  Caspian J Intern Med       Date:  2012

2.  Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland.

Authors:  S P McIlroy; V L Crawford; K B Dynan; B M McGleenon; M D Vahidassr; J T Lawson; A P Passmore
Journal:  J Med Genet       Date:  2000-03       Impact factor: 6.318

3.  Intubating conditions following rapid sequence induction with three doses of succinylcholine.

Authors:  Smita Prakash; Sushma Barde; Preeti Thakur; Anoop Raj Gogia; Rajvir Singh
Journal:  Indian J Anaesth       Date:  2012-03

4.  Prolonged neuromuscular blockade in a middle-eastern female patient homozygous for atypical plasma cholinesterase.

Authors:  David A Rico-Mora; Leslie Walton; Jose R Navas-Blanco
Journal:  Saudi J Anaesth       Date:  2018 Oct-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.